Subscribe to RSS
DOI: 10.1055/s-0030-1253558
Treatment with Neuropeptides Attenuates c-fos Expression in a Mouse Model of Fetal Alcohol Syndrome
Publication History
Publication Date:
04 May 2010 (online)
ABSTRACT
Fetal alcohol syndrome (FAS) is the most common nongenetic cause of mental retardation and is characterized by neurodevelopmental anomalies. C-fos is a cellular marker of transcriptional activity in the stress-signal pathway. Previously, we showed the treatment with NAP (NAPVSIPQ) + SAL (SALLRSIPA) reversed the learning deficit after prenatal alcohol exposure in FAS. Our objective was to evaluate if the mechanism of actions of NAP + SAL involves the stress-signal pathway differentiating c-fos expression in mouse brains after prenatal alcohol exposure. C57Bl6/J mice were treated with alcohol (0.03 mL/g) or placebo on gestational day 8. On postnatal day 40, in utero alcohol-exposed males were treated via gavage with 40 μg D-NAP and 40 μg D-SAL (n = 6) or placebo (n = 4); controls were gavaged with placebo daily (n = 12). After learning evaluation, hippocampus, cerebellum, and cortex were isolated. Calibrator-normalized relative real-time polymerase chain reaction and Western blot analysis were performed. Statistics included analysis of variance and post hoc Fisher analysis. Adult treatment with NAP + SAL restored the down-regulation of c-fos in the hippocampus after prenatal alcohol exposure (p < 0.05), but not in the cerebellum. There was no difference in c-fos expression in the cortex. Adult treatment with NAP + SAL restored the down-regulation of c-fos expression in hippocampus attenuating the alcohol-induced alteration of the stress-signal pathway.
KEYWORDS
Fetal alcohol syndrome (FAS) - c-fos - oxidative stress - NAPVSIPQ (NAP) - SALLRSIPA (SAL)
REFERENCES
- 1 May P A, Gossage J P, Kalberg W O et al.. Prevalence and epidemiologic characteristics of FASD from various research methods with an emphasis on recent in-school studies. Dev Disabil Res Rev. 2009; 15 176-192
- 2 Sokol R J, Delaney-Black V, Nordstrom B. Fetal alcohol spectrum disorder. JAMA. 2003; 290 2996-2999
- 3 Lieber C S. Microsomal ethanol-oxidizing system (MEOS): the first 30 years (1968–1998)—a review. Alcohol Clin Exp Res. 1999; 23 991-1007
- 4 Mitchell J J, Paiva M, Heaton M B. Vitamin E and beta-carotene protect against ethanol combined with ischemia in an embryonic rat hippocampal culture model of fetal alcohol syndrome. Neurosci Lett. 1999; 263 189-192
- 5 Spong C Y, Abebe D T, Gozes I, Brenneman D E, Hill J M. Prevention of fetal demise and growth restriction in a mouse model of fetal alcohol syndrome. J Pharmacol Exp Ther. 2001; 297 774-779
- 6 Wilhelm D, Bender K, Knebel A, Angel P. The level of intracellular glutathione is a key regulator for the induction of stress-activated signal transduction pathways including Jun N-terminal protein kinases and p38 kinase by alkylating agents. Mol Cell Biol. 1997; 17 4792-4800
- 7 Dragunow M, Faull R. The use of c-fos as a metabolic marker in neuronal pathway tracing. J Neurosci Methods. 1989; 29 261-265
- 8 Melia K R, Ryabinin A E, Schroeder R, Bloom F E, Wilson M C. Induction and habituation of immediate early gene expression in rat brain by acute and repeated restraint stress. J Neurosci. 1994; 14 5929-5938
- 9 Ryabinin A E. Role of hippocampus in alcohol-induced memory impairment: implications from behavioral and immediate early gene studies. Psychopharmacology (Berl). 1998; 139 34-43
- 10 Poggi S H, Goodwin K M, Hill J M et al.. Differential expression of c-fos in a mouse model of fetal alcohol syndrome. Am J Obstet Gynecol. 2003; 189 786-789
- 11 Brenneman D E, Gozes I. A femtomolar-acting neuroprotective peptide. J Clin Invest. 1996; 97 2299-2307
- 12 Brenneman D E, Phillips T M, Festoff B W, Gozes I. Identity of neurotrophic molecules released from astroglia by vasoactive intestinal peptide. Ann N Y Acad Sci. 1997; 814 167-173
- 13 Brenneman D E, Hauser J, Neale E et al.. Activity-dependent neurotrophic factor: structure-activity relationships of femtomolar-acting peptides. J Pharmacol Exp Ther. 1998; 285 619-627
- 14 Bassan M, Zamostiano R, Davidson A et al.. Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide. J Neurochem. 1999; 72 1283-1293
- 15 Zhou F C, Sari Y, Powrozek T A, Spong C Y. A neuroprotective peptide antagonizes fetal alcohol exposure-compromised brain growth. J Mol Neurosci. 2004; 24 189-199
- 16 Vink J, Auth J, Abebe D T, Brenneman D E, Spong C Y. Novel peptides prevent alcohol-induced spatial learning deficits and proinflammatory cytokine release in a mouse model of fetal alcohol syndrome. Am J Obstet Gynecol. 2005; 193(3 Pt 1) 825-829
- 17 Offen D, Sherki Y, Melamed E, Fridkin M, Brenneman D E, Gozes I. Vasoactive intestinal peptide (VIP) prevents neurotoxicity in neuronal cultures: relevance to neuroprotection in Parkinson's disease. Brain Res. 2000; 854 257-262
- 18 Steingart R A, Solomon B, Brenneman D E, Fridkin M, Gozes I. VIP and peptides related to activity-dependent neurotrophic factor protect PC12 cells against oxidative stress. J Mol Neurosci. 2000; 15 137-145
- 19 Glazner G W, Boland A, Dresse A E, Brenneman D E, Gozes I, Mattson M P. Activity-dependent neurotrophic factor peptide (ADNF9) protects neurons against oxidative stress-induced death. J Neurochem. 1999; 73 2341-2347
- 20 Webster W S, Walsh D A, Lipson A H, McEwen S E. Teratogenesis after acute alcohol exposure in inbred and outbred mice. Neurobehav Toxicol. 1980; 2 227-234
- 21 Brenneman D E, Spong C Y, Hauser J M et al.. Protective peptides that are orally active and mechanistically nonchiral. J Pharmacol Exp Ther. 2004; 309 1190-1197
- 22 Incerti M, Vink J, Roberson R, Wood L, Abebe D, Spong C Y. Reversal of alcohol-induced learning deficits in the young adult in a model of fetal alcohol syndrome. Obstet Gynecol. 2010; 115(2 Pt 1) 350-356
- 23 Jang M H, Jung S B, Lee M H et al.. Influence of maternal alcohol administration on c-Fos expression in the hippocampus of infant rats. Neurosci Lett. 2005; 378 44-48
- 24 Sim Y J, Kim H, Shin M S et al.. Effect of postnatal treadmill exercise on c-Fos expression in the hippocampus of rat pups born from the alcohol-intoxicated mothers. Brain Dev. 2008; 30 118-125
- 25 Morris R G, Garrud P, Rawlins J N, O'Keefe J. Place navigation impaired in rats with hippocampal lesions. Nature. 1982; 297 681-683
- 26 Jarrard L E. On the role of the hippocampus in learning and memory in the rat. Behav Neural Biol. 1993; 60 9-26
- 27 Pawlak R, Skrzypiec A, Sulkowski S, Buczko W. Ethanol-induced neurotoxicity is counterbalanced by increased cell proliferation in mouse dentate gyrus. Neurosci Lett. 2002; 327 83-86
- 28 Vann S D, Brown M W, Erichsen J T, Aggleton J P. Fos imaging reveals differential patterns of hippocampal and parahippocampal subfield activation in rats in response to different spatial memory tests. J Neurosci. 2000; 20 2711-2718
- 29 He J, Yamada K, Nabeshima T. A role of Fos expression in the CA3 region of the hippocampus in spatial memory formation in rats. Neuropsychopharmacology. 2002; 26 259-268
- 30 Ryabinin A E, Melia K R, Cole M, Bloom F E, Wilson M C. Alcohol selectively attenuates stress-induced c-fos expression in rat hippocampus. J Neurosci. 1995; 15(1 Pt 2) 721-730
Maddalena IncertiM.D.
Unit on Perinatal and Developmental Neurobiology, Eunice Kennedy Shriver NICHD, NIH
Bldg 9/Room 1W125, 9 Memorial Drive, Bethesda, MD 20892-0925
Email: maddalena.incerti@gmail.com